US FDA approves Novo Nordisk's Ozempic to cut risk of diabetic kidney disease progression
The U.S. FDA has approved Novo Nordisk's Ozempic for reducing the risk of kidney failure and disease progression, as well as ...
US FDA OKs monthly maintenance dosing for Eisai/Biogen's Alzheimer's drug
The U.S. Food and Drug Administration has approved monthly maintenance dosing for Japan's Eisai and partner Biogen's ...
The Financial Express22d
USFDA issues warning against use of anti-allergic nasal spray intravenously
The United St a tes Food and Drug Administration (USFDA) has warned health care professionals not to use unapproved epinephrine nasal solutions. According to a statement issued by the federal ...
Bloomberg L.P.18d
World Health Organization Urges Trump to Reconsider Exit
The World Health Organization called on the US to reconsider President Donald Trump’s decision to exit the agency, suggesting the move could undermine global health security. The planned ...
The Financial Express29d
USFDA gives nod to Lupin’s generic formulation to treat eye issues
Global pharma major Lupin Limited on Thursday announced that it has received tentative approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug ...
Hindustan Times23d
USFDA bans Red Dye No. 3, known to cause cancer in animals
Decades after scientific evidence first raised alarm, Red 3, as it is also called, is currently used in nearly 3,000 food products in the United States. Outgoing US President Joe Biden's ...
CBS News18d
Trump moves to withdraw U.S. from the World Health Organization
President Trump signed an executive order on the first day of his second term beginning the process of withdrawing the U.S. from the World Health Organization. It was among dozens of executive ...
RFK Jr. scores enough votes to advance in bid to lead U.S. health department. What's next?
Former Westchester resident and presidential candidate Robert F. Kennedy Jr. is one step closer to becoming the country's top ...
moneycontrol.com5d
Lupin shares in focus post no observation from USFDA
Lupin share price will remain in focus on February 3 as the company received no observation from the United States Food and Drug Administration (USFDA) post completion of pre-approval inspection.
Fortune18d
Trump wants to pull the U.S. out of the World Health Organization. Here’s what it would mean for Americans
© 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and ...
Devex9d
Can the US replace the World Health Organization?
WHO plays a unique role in global health, which may complicate the Trump administration's ability to replicate the agency's activities. The United States is about to find out whether the World ...
AOL11d
US FDA approves Novo Nordisk's Ozempic to cut risk of diabetic kidney disease progression
(Reuters) -The U.S. FDA has approved Novo Nordisk's Ozempic for reducing the risk of kidney failure and disease progression, as well as death due to heart problems in diabetes patients with ...